Educational information only. Not medical advice, not a diagnosis, and not an offer to sell any product. These are experimental or unapproved substances; we do not provide dosage, sourcing, or use guidance. Consult a licensed clinician. We link to official sources only.
| Therapy | Observed monthly cost | Access |
|---|---|---|
| Sermorelin acetate | ~$99 to $250 / month | Prescription / compounded |
| Bremelanotide | ~$189 to $600 / month | Prescription (Vyleesi approved for one use; compounded otherwise) |
| NAD+ | ~$105 to $350 (format-dependent) | Supplement (oral) / compounded or clinic (IV, injection, nasal) |
| CJC-1295 | ~$100 to $300 / month (approximate) | Compounded / research peptide (not FDA-approved) |
| Tesamorelin | brand ~$3,000+/mo; compounded ~$200 to $500/mo | Prescription (Egrifta approved for one use; compounded otherwise) |
Prices below are observed from public direct-to-consumer clinic pages and pricing tables, gathered without creating any account. They usually bundle a provider review with the medication. Compounded prices vary by pharmacy and dose, so read the ranges as a guide, not a quote. Each therapy has its own page with the science, the FDA status, and the sources.
Two of these have a real FDA approval for one specific use: PT-141 as Vyleesi for premenopausal women, and tesamorelin as Egrifta for an HIV-related condition. Everything else on this list, and every off-label use, is compounded and not FDA-approved. Compounded does not mean illegal, but it does mean the product is not FDA-reviewed for quality or for the marketed use, and it always needs a licensed provider.
Most peptide sellers reach buyers through search, education, and email rather than paid social ads, because ad platforms restrict prescription and peptide promotions. That is why clear, honest cost and evidence pages like these are the main way people compare options.
Oral NAD+ precursors like NMN and nicotinamide riboside are the cheapest, around 30 to 90 dollars a month. Injectable peptide programs start higher, usually around 100 to 200 dollars a month.
PT-141 is approved as Vyleesi for premenopausal women, and tesamorelin is approved as Egrifta for an HIV-related condition. Sermorelin, CJC-1295, Ipamorelin, and off-label uses of the others are compounded and not FDA-approved.
Yes, for the injectable peptides and for compounded products. They are dispensed by licensed providers and compounding pharmacies. Oral NAD+ precursors are sold as supplements and do not need a prescription.
One email when regulatory status changes or strong new evidence lands. Health topics only. Unsubscribe anytime.
Educational information only. Not medical advice, not a diagnosis, and not an offer to sell any product. These are experimental or unapproved substances; we do not provide dosage, sourcing, or use guidance. Consult a licensed clinician. We link to official sources only.